202 related articles for article (PubMed ID: 38710296)
1. Brain metastasis: An insight into novel molecular targets for theranostic approaches.
Santos L; Moreira JN; Abrunhosa A; Gomes C
Crit Rev Oncol Hematol; 2024 Jun; 198():104377. PubMed ID: 38710296
[TBL] [Abstract][Full Text] [Related]
2. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
3. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
4. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
5. The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
Pruis IJ; van Dongen GAMS; Veldhuijzen van Zanten SEM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033160
[TBL] [Abstract][Full Text] [Related]
6. Theranostics in Neurooncology: Heading Toward New Horizons.
Tolboom N; Verger A; Albert NL; Fraioli F; Guedj E; Traub-Weidinger T; Morbelli S; Herrmann K; Zucchetta P; Plasschaert SLA; Yakushev I; Weller M; Glas M; Preusser M; Cecchin D; Barthel H; Van Weehaeghe D
J Nucl Med; 2024 Feb; 65(2):167-173. PubMed ID: 38071569
[TBL] [Abstract][Full Text] [Related]
7. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases.
Dyer MR; Jing Z; Duncan K; Godbe J; Shokeen M
Nucl Med Biol; 2024; 130-131():108879. PubMed ID: 38340369
[TBL] [Abstract][Full Text] [Related]
8. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract][Full Text] [Related]
9. Radiotheranostics in Cancer Diagnosis and Management.
Jadvar H; Chen X; Cai W; Mahmood U
Radiology; 2018 Feb; 286(2):388-400. PubMed ID: 29356634
[TBL] [Abstract][Full Text] [Related]
10. Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics.
Franco Machado J; Silva RD; Melo R; G Correia JD
Molecules; 2018 Dec; 24(1):. PubMed ID: 30583594
[TBL] [Abstract][Full Text] [Related]
11. Theranostics and metabolotheranostics for precision medicine in oncology.
Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
[TBL] [Abstract][Full Text] [Related]
12. Theranostics based on AIEgens.
Wang D; Lee MMS; Xu W; Kwok RTK; Lam JWY; Tang BZ
Theranostics; 2018; 8(18):4925-4956. PubMed ID: 30429878
[TBL] [Abstract][Full Text] [Related]
13. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
14. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
15. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
16. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.
Bejarano J; Navarro-Marquez M; Morales-Zavala F; Morales JO; Garcia-Carvajal I; Araya-Fuentes E; Flores Y; Verdejo HE; Castro PF; Lavandero S; Kogan MJ
Theranostics; 2018; 8(17):4710-4732. PubMed ID: 30279733
[TBL] [Abstract][Full Text] [Related]
17. David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma.
Filippi L; Frantellizzi V; De Vincentis G
Cancer Treat Res Commun; 2021; 29():100478. PubMed ID: 34689017
[TBL] [Abstract][Full Text] [Related]
18. Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.
Ahn BC
Biomed Res Int; 2016; 2016():1680464. PubMed ID: 27239470
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in theranostics and challenges for the future.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20170893. PubMed ID: 29565650
[TBL] [Abstract][Full Text] [Related]
20. Alpha emitting nuclides in nuclear medicine theranostics.
Miederer M
Nuklearmedizin; 2022 Jun; 61(3):273-279. PubMed ID: 34624903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
